JCCC Research Seminar Featuring Dr. Harvey Herschman
COX-2 and Cancer
12:00 PM - 1:00 PM
10833 Le Conte Ave.
Los Angeles, California 90095
Harvey Herschman, Ph.D.
Distinguished Research Professor
Departments of Pharmacology and Biological Chemistry
Member, JCCC Cancer Molecular Imaging Program Area
Dr. Harvey Herschman's laboratory discovered the COX-2 gene, the target of the anti-inflammatory drugs Celebrex and Vioxx. Elevated COX-2 is a hallmark of many cancers such as colon, lung and breast. He and his colleagues are interested in the role of COX-2 in the initiation and progression of cancers. To study these areas, they are developing mouse models in which COX-2 can be conditionally over-expressed or suppressed in specific target tissues.
Light lunch served
Sponsored by the JCCC Cancer Molecular Imaging Program Area